Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004154378 | SCV003627108 | uncertain significance | not specified | 2022-07-19 | criteria provided, single submitter | clinical testing | The c.395G>A (p.G132E) alteration is located in exon 2 (coding exon 2) of the SEMG1 gene. This alteration results from a G to A substitution at nucleotide position 395, causing the glycine (G) at amino acid position 132 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |